Solid amorphous formulations for enhancing solubility and inhibiting Erlotinib crystallization during gastric-to-intestinal transfer Academic Article

authors

publication date

July 11, 2023

published in

Pharmaceutical Development and Technology Journal

Digital Object Identifier (DOI)

https://doi.org/10.1080/10837450.2023.2233612

has global citation frequency

https://vivo.tib.eu/demo/individual/gcf_W4383872662 Global Citation Count

start page

697

end page

707

volume

28

issue

7